
Sign up to save your podcasts
Or


Diagnosis and management of OAB among males can be challenging, especially given the inherent overlap in symptoms observed with Benign Prostate Hyperplasia (BPH). BPH is diagnosed and treated more frequently than OAB; however, the differences between diagnosis and treatment patterns for the two conditions highlight the potential undertreatment of OAB and misdirection of therapy for men. This episode explores various aspects of OAB in males, focusing on its unique characteristics within this population.
Disclaimer:
This presentation include products/indications which may not be approved in your country. Physicians should take into account the patient’s individual circumstances and consult the approved product information before prescribing.
Astellas’ products availability, starting dose and indications may vary from country to country. These presentations are prepared solely for education of the healthcare professionals and does not necessarily reflect the opinions or recommendations of the sponsor.
Astellas prohibits the promotion of unapproved drug usage and complies with all applicable laws, regulations, and company policies.
Approval code: INT-M-BET-202107-21
By Astellas PharmaDiagnosis and management of OAB among males can be challenging, especially given the inherent overlap in symptoms observed with Benign Prostate Hyperplasia (BPH). BPH is diagnosed and treated more frequently than OAB; however, the differences between diagnosis and treatment patterns for the two conditions highlight the potential undertreatment of OAB and misdirection of therapy for men. This episode explores various aspects of OAB in males, focusing on its unique characteristics within this population.
Disclaimer:
This presentation include products/indications which may not be approved in your country. Physicians should take into account the patient’s individual circumstances and consult the approved product information before prescribing.
Astellas’ products availability, starting dose and indications may vary from country to country. These presentations are prepared solely for education of the healthcare professionals and does not necessarily reflect the opinions or recommendations of the sponsor.
Astellas prohibits the promotion of unapproved drug usage and complies with all applicable laws, regulations, and company policies.
Approval code: INT-M-BET-202107-21